Binge eating disorder

Search with Google Search with Bing
Information
Disease name
Binge eating disorder
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT05560529 Active, not recruiting N/A Dialectical Behavioral Therapy As A Therapeutic Tool In Patients With Binge Eating Disorder March 15, 2023 August 2024
NCT05035927 Active, not recruiting Phase 2 Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating Disorder March 16, 2022 August 2025
NCT00277641 Completed Phase 3 Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity March 2006 January 2009
NCT00307190 Completed Hormone Release and Stomach Disturbances in People With Binge Eating Disorder October 2004 October 2009
NCT00330655 Completed Phase 4 An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder May 2006 July 2007
NCT00402584 Completed Phase 3 A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder August 2000
NCT00414167 Completed Phase 2/Phase 3 Craving, Binge Eating and Obesity December 2005 March 2011
NCT00511940 Completed Phase 2/Phase 3 Acamprosate in the Treatment of Binge-Eating Disorder April 2007 January 2011
NCT00514995 Completed Phase 2/Phase 3 Sodium Oxybate in the Treatment of Binge Eating Disorder August 2007 April 2011
NCT00537758 Completed N/A Treatment for Obesity and Binge Eating Disorder July 2002
NCT00601653 Completed N/A Effectiveness of Cognitive Behavioral Therapy Plus Nutritional Counseling in Promoting Weight Loss in People With Binge Eating Disorder September 2007 March 2010
NCT00777634 Completed Follow-Up Extension to the Family Study of Binge Eating Disorder June 2005 November 2009
NCT00848367 Completed N/A Binge Eating Disorder Treatment Study April 2007 December 2011
NCT00904306 Completed Phase 1/Phase 2 Binge Eating and Chromium Study July 2008 July 2011
NCT00965705 Completed N/A Stepped Care Treatment for Binge-Eating June 2009 March 2017
NCT01010789 Completed Phase 3 Armodafinil in Binge Eating Disorder (BED) November 2009 May 2015
NCT01090713 Completed Phase 3 Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder January 2010 October 2012
NCT01096251 Completed N/A STRATOB: a Randomized Controlled Clinical Trial of Cognitive Behavioural Therapy and Brief Strategic Therapy With Telecare for Binge-eating Disorder January 2008 July 2017
NCT01098435 Completed Phase 2 ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder May 2010 June 2011
NCT01208259 Completed Phase 1/Phase 2 The Psychological Treatment of Overweight Binge Eaters Minority Supplement April 1997 March 1999
NCT01208272 Completed Phase 1/Phase 2 Psychological Treatment of Overweight Binge Eaters April 1994 March 1999
NCT01282736 Completed N/A Guided Self-Help for Binge Eating Disorder June 2010 July 2014
NCT01291173 Completed Phase 2 Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder May 10, 2011 January 30, 2012
NCT01470508 Completed N/A Engaging Latino Families in Eating Disorders Treatment August 2010 March 2016
NCT01552759 Completed N/A Appetite Hormones in Binge Eating Disorder May 2007 January 2012
NCT01657019 Completed Phase 3 Open Label Extension in Adults With Binge Eating Disorder (BED) August 21, 2012 October 21, 2014
NCT01718483 Completed Phase 3 SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder November 26, 2012 September 25, 2013
NCT01718509 Completed Phase 3 SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder November 26, 2012 September 20, 2013
NCT01832792 Completed N/A Guided Self-help for Binge Eating August 2013 March 2017
NCT02659475 Completed Phase 2 Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED) September 2015 September 2016
NCT00041743 Completed N/A Treatment of Binge Eating Disorder July 2002 December 2007
NCT02564588 Completed Phase 2/Phase 3 Dasotraline Binge Eating Disorder Study October 2015 October 2016
NCT00032760 Completed Phase 2/Phase 3 Meditation-Based Treatment for Binge Eating Disorder March 2002 March 2004
NCT02684279 Completed Phase 3 Dasotraline Binge Eating Disorder Extension Study February 29, 2016 June 24, 2019
NCT02834299 Completed N/A Dialectical Behavior Therapy Guided Self-Help for Binge Eating Disorder September 20, 2016 March 20, 2018
NCT02868619 Completed N/A Binge Eating Disorder and Obesity : Functional MRI Study December 5, 2014 March 10, 2021
NCT03107026 Completed Phase 3 A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder March 31, 2017 May 16, 2018
NCT03107221 Completed N/A Eating Disorders: Online Self-help & Usual Treatment (TAU) vs TAU Only August 2016 October 2017
NCT03234881 Completed N/A Weight Loss Treatment for Veterans With Binge Eating January 8, 2018 May 23, 2023
NCT03604172 Completed N/A Neural Response to Food Stimuli: fMRI Changes Following Cognitive Behavioral Therapy for Binge Eating Disorder August 8, 2018 November 22, 2021
NCT04432311 Completed N/A Comparing a Group-based Guided Self-help Approach to Pure Self-help for the Treatment of BED January 5, 2021 July 20, 2023
NCT04876183 Completed N/A Evaluation of a Web-Based Intervention for Binge Eating Disorder January 12, 2021 August 3, 2022
NCT02009163 Completed Phase 3 Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder January 27, 2014 April 8, 2015
NCT02038712 Completed N/A fMRI and Ghlrein in Obesity and Binge Eating Disorder June 2006 September 2013
NCT02043496 Completed N/A Integrative Cognitive-Affective Therapy for Binge Eating Disorder December 2013 August 2017
NCT02079935 Completed N/A Treatment of Eating Disorders by Physical Activity and Nutrition Counseling March 2014 January 31, 2019
NCT02317744 Completed N/A Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo December 2014 September 2016
NCT02399982 Completed Phase 1 Smartphone Technology and CBT-GSH in Binge Eaters February 2013 March 2016
NCT02464345 Completed N/A Healthy Approach to weIght Management and Food in Eating Disorders (HAPIFED) July 7, 2015 March 31, 2019
NCT02503098 Completed N/A Optimizing a Smartphone Application for Individuals With Eating Disorders November 23, 2016 September 13, 2018
NCT02528409 Completed Phase 2 Vortioxetine for Binge Eating Disorder June 2016 November 1, 2018
NCT02553824 Completed Phase 1 FDA Approved Medication to Reduce Binge Eating and/or Purging October 30, 2015 April 15, 2017
NCT02555553 Completed N/A Noom Monitor for Binge Eating April 2016 May 1, 2018
NCT05897398 Not yet recruiting SEMASEARCH, Retrospective/Prospective Cohort Nested at ATUc/AP2 WEGOVY® April 2024 April 2026
NCT04602936 Recruiting Phase 4 Solriamfetol in Binge Eating Disorder June 15, 2021 December 30, 2024
NCT01888406 Unknown status N/A Binge Eating Self-help Treatment for University Students January 2013 September 2014
NCT01567670 Unknown status Phase 2/Phase 3 Clinical Trial on Binge Eating Disorder, Treatment With Naloxone Spray August 2011
NCT02940613 Unknown status N/A Using Visual Feedback to Influence Rapid Response in the Treatment of Eating Disorders December 2016 December 2021
NCT02659488 Unknown status Phase 2 Lisdexamfetamine in Binge Eating Disorder (BED): fMRI Effects September 2015 December 2017
NCT01868204 Unknown status Pharmacogenetic and Neurofunctional Brain Areas Study in Obese Patients With Binge Eating Disorder June 2013 March 2014
NCT02382497 Unknown status N/A New Treatment Perspectives in Eating Disorders: the Efficacy of Non-invasive Brain-directed Treatment July 2014 July 2023
NCT01837953 Unknown status N/A Stepped Care for Binge Eating Disorder: Predicting Response to Minimal Intervention in a Randomized Controlled Trial November 2012 September 2017
NCT02978742 Withdrawn N/A Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder September 2017 September 2019
NCT01106053 Withdrawn Phase 3 Pramipexole for Binge Eating Disorder April 2010